Strandwitz, Philip

Philip StrandwitzPhilip Strandwitz, PhD
CEO and Co-founder, Holobiome, Inc.
Visiting Scholar, Antimicrobial Discovery Center
Department of Biology, Northeastern University
Boston, MA

The Gut-Brain-Axis – Potential Therapeutic Targets

Born in Wisconsin but brought to Boston by the allure of biotechnology, Philip is a microbial ecologist with expertise in the human microbiome, bacterial cultivation, and the gut-brain-axis. He received his Bachelor’s in Microbiology from the University of La Crosse – Wisconsin, and his PhD from Northeastern University in Boston, MA, where he focused on cultivating unique bacteria from the human gut microbiota, as well as studying their ability to modulate neurotransmitters. Philip’s work has been published in top journals like Nature Microbiology, and he has presented at numerous scientific and industrial conferences, including those sponsored by the New York Academy of Science and BIO. He is now CEO at Holobiome, a gut-brain-axis microbiome company he co-founded, located in Kendall Square in Cambridge, MA. Here he has assembled and manages a team of leaders in neuroscience, microbiology, and drug development, with the goal to translate microbiome science into interventions to treat diseases of the nervous system, with planned expansion into other markets.

Conference Lecture Summary

This activity received educational support from:

Steven & Alexandra Cohen Foundation



And commercial support from:

IGeneX Inc.

2019 Scientific Conference Jointly Provided by